Retraction: Recurrent Glioblastoma: Where we stand
- PMID: 29404292
- PMCID: PMC5763624
- DOI: 10.4103/2278-330X.221358
Retraction: Recurrent Glioblastoma: Where we stand
Abstract
[This retracts the article on p. 163 in vol. 4, PMID: 26981507.].
Retraction of
-
Recurrent Glioblastoma: Where we stand.South Asian J Cancer. 2015 Oct-Dec;4(4):163-73. doi: 10.4103/2278-330X.175953. South Asian J Cancer. 2015. Retraction in: South Asian J Cancer. 2017 Oct-Dec;6(4):153. doi: 10.4103/2278-330X.221358. PMID: 26981507 Free PMC article. Retracted. Review.
Similar articles
-
Retraction.Saudi J Anaesth. 2020 Jul-Sep;14(3):422. doi: 10.4103/1658-354X.285417. Saudi J Anaesth. 2020. PMID: 32934651 Free PMC article.
-
Retraction note to four articles published in World Journal of Orthopaedics.World J Orthop. 2018 Mar 18;9(3):58-59. doi: 10.5312/wjo.v9.i3.58. eCollection 2018 Mar 18. World J Orthop. 2018. PMID: 29564215 Free PMC article.
-
Retraction.Saudi J Anaesth. 2022 Jan-Mar;16(1):144. doi: 10.4103/1658-354X.334743. Saudi J Anaesth. 2022. PMID: 35261616 Free PMC article.
-
Retraction Note.Iran Red Crescent Med J. 2016 Mar 3;18(3):e43586. doi: 10.5812/ircmj.43586. eCollection 2016 Mar. Iran Red Crescent Med J. 2016. PMID: 27830082 Free PMC article.
-
Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway [Retraction].Am J Transl Res. 2021 May 15;13(5):5746. eCollection 2021. Am J Transl Res. 2021. PMID: 34150184 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources